Embattled drugmaker Indivior raises forecasts on Suboxone strength
(Reuters) – Indivior Plc on Tuesday raised its full-year forecasts as the embattled British drugmaker’s best-selling opioid addiction drug Suboxone…
Indivior loses appeal to block generic Suboxone opioid treatments
(Reuters) – A divided federal appeals court on Friday ruled against Indivior Plc in its bid to stop Dr. Reddy’s…
Indivior says Reckitt settlement in U.S. unrelated to its cases
(Reuters) – Drugmaker Indivior Plc said on Thursday its former parent Reckitt Benckiser’s $1.4 billion settlement with authorities in the…
Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals…
Reckitt to pay $1.4 billion to end U.S. opioid addiction treatment probes
(Reuters) – Reckitt Benckiser has agreed to pay up to $1.4 billion to resolve U.S. claims that its former pharmaceuticals…